Acadia Healthcare Company, Inc.
$27.84
▲
1.23%
2026-04-21 05:02:02
www.acadiahealthcare.com
NMS: ACHC
Explore Acadia Healthcare Company, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.56 B
Current Price
$27.84
52W High / Low
$28.48 / $11.43
Stock P/E
—
Book Value
$21.55
Dividend Yield
—
ROCE
7.76%
ROE
-40.96%
Face Value
—
EPS
$-12.16
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
19,000
Beta
0.71
Debt / Equity
124.03
Current Ratio
1.55
Quick Ratio
1.54
Forward P/E
15.48
Price / Sales
0.72
Enterprise Value
$5.11 B
EV / EBITDA
8.85
EV / Revenue
1.54
Rating
Buy
Target Price
$22.71
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Healthcare Services Group, Inc. | $19.32 | 22.48 | $1.33 B | — | 8.94% | 11.69% | $22.98 / $9.12 | $7.33 |
| 2. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
| 3. | P3 Health Partners Inc. | $2.83 | — | $18.75 M | — | -242.67% | -69.53% | $11.3 / $1.52 | $-47.24 |
| 4. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 5. | Surgery Partners, Inc. | $14.31 | — | $1.85 B | — | 6.27% | 2.76% | $24.18 / $11.41 | $13.37 |
| 6. | Pediatrix Medical Group, Inc. | $23.19 | 11.69 | $1.93 B | — | 12.93% | 20.28% | $24.99 / $11.84 | $10.68 |
| 7. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 821.46 M | 851.57 M | 869.23 M | 770.5 M | 774.24 M | — |
| Operating Profit | 47.64 M | 119.52 M | 142.3 M | 78.5 M | 103.46 M | — |
| Net Profit | -1.18 B | 36.25 M | 30.13 M | 8.37 M | 32.62 M | — |
| EPS in Rs | -12.79 | 0.39 | 0.33 | 0.09 | 0.35 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.31 B | 3.15 B | 2.93 B | 2.61 B |
| Operating Profit | 387.96 M | 522.28 M | 513.01 M | 467.69 M |
| Net Profit | -1.1 B | 255.61 M | -21.67 M | 273.14 M |
| EPS in Rs | -11.98 | 2.78 | -0.24 | 2.97 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.53 B | 5.96 B | 5.36 B | 4.99 B |
| Total Liabilities | 3.39 B | 2.77 B | 2.47 B | 2.09 B |
| Equity | 1.95 B | 3.07 B | 2.78 B | 2.81 B |
| Current Assets | 814.14 M | 577.49 M | 596 M | 506.12 M |
| Current Liabilities | 525.19 M | 577.92 M | 885.78 M | 388.33 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 131.9 M | 129.69 M | 462.34 M | 380.57 M |
| Investing CF | -556.21 M | -736.48 M | -397.22 M | -305.83 M |
| Financing CF | 481.25 M | 583.02 M | -62.7 M | -110.9 M |
| Free CF | -439.91 M | -560.69 M | 38.21 M | 84.42 M |
| Capex | -571.81 M | -690.38 M | -424.13 M | -296.15 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.69% | 12.2% | — | — |
| Earnings Growth % | 1279.73% | -107.93% | — | — |
| Profit Margin % | 8.1% | -0.74% | 10.46% | — |
| Operating Margin % | 16.56% | 17.52% | 17.92% | — |
| Gross Margin % | 96.43% | 96.38% | 96.16% | — |
| EBITDA Margin % | 19.27% | 6.46% | 21.52% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.